HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takako Kitagawa Selected Research

Bevacizumab (Avastin)

9/2013[Comparison of 1-year treatment outcome of intravitreal pegaptanib sodium versus bevacizumab for myopic choroidal neovascularization].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takako Kitagawa Research Topics

Disease

2Choroidal Neovascularization
09/2013 - 04/2013
1Vision Disorders (Hemeralopia)
04/2013

Drug/Important Bio-Agent (IBA)

2pegaptanib (Macugen)FDA Link
09/2013 - 04/2013
1Bevacizumab (Avastin)FDA Link
09/2013
1Retinaldehyde (Retinal)IBA
04/2013

Therapy/Procedure

2Intravitreal Injections
09/2013 - 04/2013
1Injections
04/2013
1Aftercare (After-Treatment)
04/2013